Edwards Lifesciences Corp

Common Name
Edwards Lifesciences
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
15,800
Ticker
EW
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Edwards Lifesciences Corporation is a leading healthcare company primarily known for its innovative medical devices focused on cardiovascular conditions. The firm's primary function revolves around th...

Edwards Lifesciences's GHG Emissions Data Preview

In 2024, Edwards Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Edwards Lifesciences has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Edwards Lifesciences’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Edwards Lifesciences’s data sources below and access millions more through our Disclosure Search.

a. Edwards Lifesciences's ESG Data Spreadsheet 2024
a. Edwards Lifesciences's ESG Data Spreadsheet 2024
b. Edwards Lifesciences's CDP Climate sourced from company’s website 2022
b. Edwards Lifesciences's CDP Climate sourced from company’s website 2022

Insights into Edwards Lifesciences's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Edwards Lifesciences amounted to 47,553 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Edwards Lifesciences decreased by 9.2%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Edwards Lifesciences's Scope 1 Emissions Over Time

201820192020202120222023202405 k10 k15 k20 ktCO2e+9%+4%0%+25%-11%-3%
  • Total Scope 1
  • Year-over-Year Change

What are Edwards Lifesciences's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Edwards Lifesciences were 15,682 metric tons of CO₂ equivalent (tCO₂e). a

Has Edwards Lifesciences reduced its Scope 1 emissions over time?

Since 2018, Edwards Lifesciences's Scope 1 emissions have increased by 23.88%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2023), Edwards Lifesciences's Scope 1 emissions decreased by 2.72%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a

What are Edwards Lifesciences's Scope 2 emissions?

In 2024, Edwards Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 22,393 tCO₂e using the market-based method and 31,871 tCO₂e using the location-based method. a

Has Edwards Lifesciences reduced its Scope 2 emissions over time?

Since 2018, Edwards Lifesciences's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have increased by 13.35%, reflecting a rising long-term trend in Scope 2 emissions over time. a

Compared to the previous year (2023), Edwards Lifesciences's Scope 2 emissions (Location-Based) fell by 12.08% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does Edwards Lifesciences use for Scope 2 reporting?

In 2024, Edwards Lifesciences reported its Scope 2 emissions using the market-based method and using the location-based method. a

Edwards Lifesciences's Scope 2 Emissions Over Time

201820192020202120222023202409.5 k19 k28.5 k38 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based

Insights into Edwards Lifesciences’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Edwards Lifesciences reported Scope 1 greenhouse gas (GHG) emissions of 15,682 tCO₂e and total revenues of USD 5,439 millions. This translates into an emissions intensity of 2.88 tCO₂e per millions USD. a

Edwards Lifesciences's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)IInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MIncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MResmedYear: 2023Scope 1: 4,453 tCO2eRevenue: $M 4,223Scope 1 Intensity: 1.05 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MBio Rad LaboratoriesYear: 2022Scope 1: 21,216 tCO2eRevenue: $M 2,802Scope 1 Intensity: 7.57 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MZoetisYear: 2023Scope 1: 111,637 tCO2eRevenue: $M 8,544Scope 1 Intensity: 13.07 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MAgilent TechnologiesYear: 2024Scope 1: 29,698 tCO2eRevenue: $M 6,510Scope 1 Intensity: 4.56 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2023Scope 1: 5,383 tCO2eRevenue: $M 3,622Scope 1 Intensity: 1.49 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$M

How does Edwards Lifesciences's GHG emissions intensity compare to its peers?

In 2024, Edwards Lifesciences reported a Scope 1 emissions intensity of 2.88 tCO₂e per millions USD. Compared to the peer group median of 2.68 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Edwards Lifesciences rank on GHG emissions intensity within its industry?

In 2024, Edwards Lifesciences ranked 12 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Edwards Lifesciences is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Edwards Lifesciences's GHG Emissions Dataset?
Sign Up